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Abstract
Background: Horizontal transfer of mobile genetic elements (MGEs) that carry virulence and antimicrobial resistance
genes mediates the evolution of methicillin-resistant Staphylococcus aureus, and the emergence of new MRSA clones.
Most MRSA lineages show an association with specific MGEs and the evolution of MGE composition following clonal
expansion has not been widely studied.
Results: We investigated the genomes of 1193 S. aureus bloodstream isolates, 1169 of which were MRSA, collected in
the UK and the Republic of Ireland between 2001 and 2010. The majority of isolates belonged to clonal complex (CC)
22 (n = 923), which contained diverse MGEs including elements that were found in other MRSA lineages. Several MGEs
showed variable distribution across the CC22 phylogeny, including two antimicrobial resistance plasmids (pWBG751-like
and SAP078A-like, carrying erythromycin and heavy metal resistance genes, respectively), a pathogenicity island carrying
the enterotoxin C gene and two phage types Sa1int and Sa6int. Multiple gains and losses of these five MGEs
were identified in the CC22 phylogeny using ancestral state reconstruction. Analysis of the temporal distribution of the five
MGEs between 2001 and 2010 revealed an unexpected reduction in prevalence of the two plasmids and the
pathogenicity island, and an increase in the two phage types. This occurred across the lineage and was not correlated
with changes in the relative prevalence of CC22, or of any sub-lineages within in.
Conclusions: Ancestral state reconstruction coupled with temporal trend analysis demonstrated that epidemic MRSA
CC22 has an evolving MGE composition, and indicates that this important MRSA lineage has continued to adapt to
changing selective pressure since its emergence.
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Background
Staphylococcus aureus is a major cause of human disease
worldwide. The pathogenesis of S. aureus infection has
been associated with a range of chromosomally-encoded
virulence factors. These include exotoxins that damage
host cell membranes such as haemolysins and phenol
soluble modulins (PSMs), and immune evasion mole-
cules such as protein A and aureolysin [1, 2]. However,
the success of S. aureus as a pathogen has also been fa-
cilitated by its capacity to rapidly evolve through hori-
zontal gene transfer. Mobile genetic elements (MGEs)
mediate the acquisition of novel virulence factors and
are associated with some of the most potent S. aureus
virulence molecules, including Panton-Valentine leukoci-
din and toxic shock syndrome toxin [3]. Equally import-
ant is the role of MGEs in accelerating S. aureus
adaptation to environmental pressures through transfer
of antimicrobial resistance genes. The most clinically sig-
nificant example is the Staphylococcal Cassette Chromo-
some mec (SCCmec) element, which carries the mecA/C
gene encoding methicillin resistance [4].
The widespread clinical use of β-lactam antibiotics and
resulting selective pressure for resistance has been associ-
ated with the global emergence and spread of SCCmec in
S. aureus, which has been instrumental in the evolution
and success of this pathogen in recent years [5]. Multi-
locus sequence typing (MLST) has demonstrated that
MRSA isolates belong to a limited number of clonal
complexes (CCs) [6]. More recently, whole-genome
sequencing (WGS) and reconstruction of phylogenetic re-
lationships between MRSA isolates derived from the same
CC has demonstrated that MRSA has become widespread
predominantly through a process of clonal expansion [7–9].
Several major MRSA clones have emerged, which involved
independent SCCmec acquisitions by distinct S. aureus line-
ages such as CC5, CC8, CC22, CC30 and CC45 [10].
However, acquisition of SCCmec is not the sole event
involved in the emergence of MRSA clones. Other evolu-
tionary changes occur such as the acquisition of additional
MGEs that collectively constitute molecular markers of a
new MRSA clone [11].
Contemporary MRSA clones include the epidemic
MRSA-15 (EMRSA-15), which belongs to CC22. The
first reported isolation of EMRSA-15 was in the UK in
the early 1990s, and it has since become the dominant
hospital-associated MRSA (HA-MRSA) in the country
[12, 13]. EMRSA-15 subsequently spread beyond the
UK, with rapid expansion across Europe to become the
dominant HA-MRSA lineage in Australia and Singapore
[14–16]. Whole genome analysis of CC22 isolates did
not reveal a single prominent genetic element that could
explain the success of EMRSA-15 clone, with a combin-
ation of genetic variations observed, of which the most
notable were determinants of antimicrobial resistance [9].
Reconstruction of evolutionary events that led to the
emergence of EMRSA-15 revealed acquisition of muta-
tions in gyrA/grlA genes conferring resistance to fluoro-
quinolones followed by a temporal increase in the average
number of resistance markers [9]. Additionally, EMRSA-
15 was found to suffer a lower fitness cost due to fluoro-
quinolone resistance than other MRSA clones [17].
The use of WGS to study bacterial pathogens is a rap-
idly expanding field and has given unprecedented
insights into the evolution and epidemiology of species
such as S. aureus. WGS has provided access to bacterial
pan-genomes, which facilitates the non-targeted analysis
of genomic diversity. This is particularly relevant to S.
aureus as MGEs represent around 20% of its total
genome content [18]. MGEs can be rapidly lost and ac-
quired, and WGS can now be used to study the flux of
MGEs in bacterial populations to gain better under-
standing of how their evolutionary trajectory changes
with the rise and fall of epidemic clones. Here, using
WGS data of 1193 S. aureus bloodstream isolates col-
lected in the UK and the Republic of Ireland between
2001 and 2010, we conducted a broad analysis of MGE
carriage by the dominant MRSA CC22. We defined
MGE diversity within the MRSA CC22 population, and
investigated instances of inter-lineage MGE distribution
involving CC22 and other co-circulating MRSA lineages.
We identified several MGEs that were variably distrib-
uted across the CC22 phylogeny due to frequent loss
and gain events. Temporal changes in MGE carriage
were observed, which included a fall in prevalence of
elements associated with antimicrobial resistance and
virulence. Gaining novel insights into the evolution of
MGE composition within an epidemic MRSA population
could provide answers relevant to the control of
antimicrobial resistance and more broadly reveal evolu-
tionary strategies employed by the highly successful line-
ages such as MRSA CC22.
Results
Collection overview
The analysis was conducted on 1193 S. aureus blood-
stream isolates, the majority of which were MRSA
(n = 1169, 98%; see Additional file 1: Table S1). Isolates
were sampled between 2001 and 2010 across the UK
(England, Wales, Scotland and Northern Ireland) and
the Republic of Ireland, providing a broad temporal and
regional overview of the population structure of MRSA
derived from invasive disease. The population consisted
of 14 clonal complexes, the dominant CC being CC22
(n = 923, 77%) followed by CC30 (n = 180, 15%). Less
common were CC5 (n = 30 2.5%), CC8 (n = 25, 2.1%) and
CC1 (n = 12, 1.0%). The remaining nine CCs were repre-
sented by less than 1% of all isolates and consisted of CC9,
CC15, CC20, CC25, CC45, CC59, CC80, CC97 and
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CC779. Only CC5, CC22 and CC30 were detected in
every sampling year. A temporal trend was observed for
the distribution of CC22 and CC30, with an increase in
the prevalence of CC22 and a fall in the sampling of CC30
over time (see Additional file 2: Figure S1). This is consist-
ent with previous findings for MRSA in the UK [13, 19].
The phylogenetic relationships between CC22 isolates
were reconstructed based on a core genome alignment
that contained 22,852 SNP sites. This revealed that the
CC22 population was composed predominantly of the
EMRSA-15 clone (914/923, 99%; see Additional file 2:
Figure S2). The phylogeny of CC30 isolates was recon-
structed based on a core genome alignment that con-
tained 6227 SNP sites and, similarly to the findings for
CC22, the CC30 lineage was dominated by representa-
tives of an epidemic MRSA clone, EMRSA-16 (176/180,
98%, see Additional file 2: Figure S2).
Mobile genetic elements in MRSA CC22
Whole-genome assemblies of all MRSA CC22 isolates
were evaluated for the presence of MGEs. Sequence
fragments were categorised as putative SCC elements,
pathogenicity islands, transposons or plasmids based on
the sequence, and/or insertion site if chromosomal. The
carriage of phages was evaluated based on the presence
of phage-associated integrase genes, as described previ-
ously [20]. Analysis of entire phage genomes from short
reads was not possible due to assembly across multiple
contigs resulting from their mosaic structure.
All of the MGEs identified are described in Additional
file 3: Table S2. Across all CC22 isolates a total of 37 dis-
tinct MGE sequences were identified together with five
distinct phage types. Elements that were highly prevalent
in CC22 consisted of a chromosomally integrated Tn552-
like transposon carrying the penicillin resistance blaZ
gene (n = 923, 100%), and methicillin resistance determin-
ant SCCmec IVh (n = 905, 98%). Also common was a
pathogenicity island carrying the enterotoxin C gene sec
(n = 564, 61%). This island (referred to as SaPIsec) shared
complete sequence identity with a region of the CC22 refer-
ence genome strain H-EMRSA15 (GenBank CP007659).
Most isolates also revealed carriage of two antimicrobial re-
sistance plasmids: a 2.5 kb pWBG751-like element carrying
the erythromycin resistance gene ermC (n = 665, 72%), and
a 32 kb SAP078A-like plasmid carrying a cluster of heavy
metal resistance genes composed of cadA, copB, mco and
arsAB (n = 499, 54%). For the purpose of this work the
pWBG751-like and SAP078A-like plasmids are referred to
as P1-ermC and P2-hm (heavy metal), respectively.
The remaining elements were found at a frequency of
between 0.1% (single isolate only) to 3.7% (n = 34). A
further four pathogenicity island elements were detected
in CC22 including SaPI2 carrying toxic shock syndrome
toxin tst [21] and SaPI4 [22], although each was found
in no more than 10 CC22 isolates. While the majority of
CC22 isolates carried SCCmec type IVh, other types (IVa,
IVc and V) were also detected. Carriage of arginine cata-
bolic mobile element (ACME) type II was detected in 34
CC22 isolates. The ACME element typically forms a
composite island together with SCCmec (ACME-SCCmec-
CI) located within the orfX gene [23]. A previous report of
ACME type II in CC22 described two variants of ACME-
SCCmec-CI, where ACME was associated with either
SCCmec type IVa or type IVh, the latter being the most
common [24]. Here, we made a similar observation in that
10 of the ACME positive CC22 isolates carried SCCmec
IVa and the remaining 24 contained SCCmec type IVh.
Other composite islands within the orfX gene were also
observed, including two distinct SCC elements of
unknown function as well as SCCfus, which contains
fusidic acid resistance gene fusC. All SCC elements were
observed in SCCmec IVh positive isolates.
In addition to the broadly distributed P1-ermC and
P2-hm plasmids, 21 further putative plasmids or plasmid
fragments were detected in CC22, most of which carried
either a single or multiple antimicrobial resistance deter-
minants. Distinct elements carrying homologous resist-
ance genes were detected. In particular, resistance genes
ileS (mupirocin resistance gene), tetK (tetracycline resist-
ance gene) and qacC (multidrug efflux protein gene)
were each associated with at least 3 different elements.
Other resistance genes found on putative plasmids in-
cluded catA (chloramphenicol resistance gene), aadD
(kanamycin resistance gene) and bleO (bleomycin resist-
ance gene). However, all were very infrequent in CC22
with each found in no more than 6 isolates, which may
indicate transient carriage by this population.
Analysis of phage type distribution revealed that the ma-
jority of CC22 isolates carried Sa2int (n = 887, 96%) and
Sa3int (n = 850, 92%) phage types. Based on mapping to a
complete reference sequence of Sa2int phage present in
CC22 strain HO 5096 0412, most Sa2int-positive isolates
(883/887) carried a closely related variant (mapping se-
quence identity 95–100%, coverage 92–100%). Of the
remaining 4 isolates, two carried Sa2int phage containing
the Panton-Valentine leukocidin gene pvl although neither
were the EMRSA-15 clone. All but one Sa3int-positive
CC22 isolates (849/850) carried phage that shared high
sequence identity with the Sa3int-carried by the CC22
strain HO 5096 4012 (mapping sequence identity 95–
100%, coverage 91–100%). The CC22 population also con-
tained a lower prevalence of phages Sa1int (n = 172, 19%)
and Sa6int (n = 167, 18%).
Distribution of MGEs identified in MRSA CC22 across S.
aureus population
We investigated whether MGEs that were detected in
MRSA CC22 isolates also occur in representatives of
Jamrozy et al. BMC Genomics  (2017) 18:684 Page 3 of 12
other lineages. The distribution of all identified MGEs is
presented in Fig. 1, which shows the phylogeny of all
1193 S. aureus isolates based on core genome alignment
consisting of 160,857 SNP sites. Amongst the 37 MGEs
that were detected in CC22, 19 were also observed in
other CCs, which is consistent with inter-lineage dissem-
ination. Specific elements were observed to be common
to several CCs. The most frequently shared MGEs
among different lineages were small antimicrobial
resistance plasmids such as P1-ermC, the tetK-positive
plasmid P8, and the aadD-bleO-positive plasmid P10.
Despite a low overall prevalence, SCCmec type IVc was
detected in four non-CC22 lineages. Interestingly, we
also observed instances where an element identified in
CC22 was notably more prevalent in a non-CC22
lineage. This included pathogenicity islands SaPI-2 and
SaPI-4 that were highly prevalent in CC30 (96% and
98%, respectively), SCCfus observed in over half of CC1
isolates, and the addD-bleO-positive plasmid P10, which
was present in the majority of CC30 and over half of
CC5 isolates. The sporadic acquisition of diverse MGEs
might represent a unique feature of CC22. Nevertheless,
our data reveals that a number of chromosomally
integrated as well as extra-chromosomal elements that
have a particular association with a specific lineage can
be also infrequently observed in another CC.
Fig. 1 Phylogeny of 1193 S. aureus bloodstream isolates and distribution of analysed MGEs. The colour-coded column indicates clades representing
the most common lineages: CC1, CC5, CC8, CC22 and CC30. All isolates were screened for carriage of MGEs detected in MRSA CC22. A rooted approximately
maximum-likelihood phylogenetic tree was annotated with the distribution of all identified MGEs. Red horizontal lines indicate the presence of MGE. Names
of MGEs detected in both CC22 and non-CC22 isolates are highlighted in blue. Putative plasmids were assigned a numeric ID plus the name of antimicrobial
resistance gene (if applicable). For chromosomally integrated elements, ID names were assigned based on close homology to a previously described
element as identified with Basic Local Alignment Search Tool (BLAST) based on sequence identity cut-off of 99%, or a numeric ID was assigned (name
in italics)
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MGE distribution in the context of MRSA CC22 phylogeny
The variable frequency of certain MGEs in MRSA CC22
provided an opportunity to investigate the evolution-
ary dynamics of MGE acquisition and maintenance in
this population over a 10-year period. For this we
focused on the MGEs that were frequent but not uni-
formly present in CC22, namely plasmids P1-ermC
and P2-hm, pathogenicity island SaPIsec and phages
Sa1int and Sa6int (Fig. 2).
All five MGEs were variably distributed across the
CC22 phylogenetic tree and present in multiple clades,
revealing an on-going process of horizontal acquisition
and/or loss (Fig. 2). The relationship between the top-
ology of the tree and MGE carriage was evaluated by
measuring the phylogenetic signal (s2 value) of each
element based on the phylogenetic generalized linear
mixed model for binary data [25]. A value of s2 = 0
suggests no phylogenetic signal and so no association
between the occurrence of a trait and phylogenetic
structure (i.e. random distribution). On the contrary, in-
creasing values of s2 denote a stronger phylogenetic
signal and can be interpreted as a more stable vertical
heritability of a trait. Among the five MGEs, the calcu-
lated s2 value ranged from 3 to 13. The lowest relative
measure of phylogenetic signal was observed for P1-
ermC (s2 = 3), followed by P2-hm (s2 = 5), Sa6int
(s2 = 9), Sa1int (s2 = 11) and SaPIsec (s2 = 13). This
implies that while the distribution of the analysed MGEs
amongst CC22 isolates was correlated with their
phylogenetic relationship, the strength of this association
varied and was lower for the two plasmids P1-ermC and
P2-hm in comparison with SaPIsec, Sa1int and Sa6int.
This suggests that the distribution of these two plasmids
was to a greater degree affected by independent horizon-
tal acquisition events or sporadic losses than in the case
of the chromosomally integrated MGEs, which are more
frequently acquired vertically from a common ancestor.
To further study the correlation between phylogeny
and carriage of the five MGEs we conducted ancestral
state reconstruction (ASR) of each element as a discrete
trait (MGE presence or absence) by performing stochas-
tic character mapping on the phylogenetic tree [26]. The
estimated total number of transitions between the two
states revealed that for P1-ermC, P2-hm and SaPIsec loss
was more common, in contrast to Sa1int and Sa6int,
where the gain event was more prevalent (Fig. 3). We
investigated the estimated ancestral character states for
all five MGEs at the internal node leading to the
EMRSA-15 clade, which represents the vast majority of
the analysed CC22 population. The node was predicted
as positive for P1-ermC (mean = 0.935), P2-hm
(mean = 0.993) and SaPIsec (mean = 1), but negative for
Sa1int (mean = 0.001) and Sa6int (mean = 0.007). This
is consistent with the estimated transition counts and
shows that the heterogeneous MGE distribution across
the CC22 phylogeny is driven by both sporadic losses
(mostly P1-ermC, P2-hm and SaPIsec) as well as inde-
pendent acquisition events (mostly Sa1int and Sa6int).
Fig. 2 Phylogeny of MRSA CC22 isolates and MGE carriage. A rooted maximum-likelihood phylogenetic tree was annotated with the distribution
of selected MGEs: P1-ermC, P2-hm, SaPIsec, Sa1int and Sa6int. Branches of clade representing the EMRSA-15 population are shown in red
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Plasmid P1-ermC demonstrated the highest number of
overall state changes for both transition types, with the
high number of estimated MGE losses accompanied by
an equally frequent gain events. To rule out the possibil-
ity that the observed high rates of changes in the status
of plasmid P1-ermC carriage was an artefact of sample
processing leading to loss of this MGE during laboratory
culture, we assessed the incidence of heterogeneous P1-
ermC carriage amongst genetically identical isolates. We
detected 22 pairs of isolates across the CC22 phylogeny
with 0 SNPs difference at the core genome. Only a single
pair revealed variable plasmid distribution (one of the
isolates negative for P1-ermC), suggesting that in most
cases plasmid carriage by highly related isolates is stable.
Temporal variation in distribution of MRSA CC22 MGEs
We investigated the temporal dynamics of the five ele-
ments: P1-ermC, P2-hm, SaPIsec, Sa1int and Sa6int. All
MGEs except for Sa1int were detected in every year
between 2001 and 2010. In contrast, none of the isolates
collected in either 2001 or 2002 carried phage Sa1int.
Analysis of MGE frequency across years revealed a tem-
poral trend, with a fall in prevalence of P1-ermC, P2-hm
and SaPIsec but increase in frequency of Sa1int and
Sa6int. The prevalence of P1-ermC, P2-hm and SaPIsec
in CC22 between 2001 and 2010 fell from 74% to 55%,
70% to 43% and 78% to 52%, respectively (Fig. 4). In
contrast, the carriage of Sa6int increased from 6% in
2001 to 22% in 2010. Isolates carrying Sa1int emerged in
2003 and increased in frequency from 11% (in 2003) to
31% in 2010. To test the significance of these shifts in
MGE prevalence over time we used logistic regression to
measure the effect and significance of the year of sam-
pling on the presence of MGEs. For all elements, there
was a significant association between the year of sam-
pling and MGE carriage (p < 0.001 for P1-ermC, P2-hm,
SaPIsec and Sa1int; p = 0.02 for Sa6int). We also tested
whether MGE carriage status was correlated with lineage
divergence as such relationship can indicate an evolu-
tionary trajectory towards either MGE loss or gain. For
this we measured the phylogenetic root-to-tip distance
of all isolates and calculated the effect of this variable on
MGE carriage status. A negative correlation between
root-to-tip distance and presence of an element was ob-
served for P1-ermC, P2-hm and SaPIsec (see Additional
file 2: Figure S3), although this was more significant for
P2-hm and SaPIsec (p < 0.001 and p = 0.004, respect-
ively) than P1-ermC (p = 0.02). This is in agreement
with our observation that P1-ermC can be frequently
lost and re-acquired, which would likely undermine the
strength of association between divergence and plasmid
carriage status. In contrast a positive correlation between
root-to-tip distance and MGE carriage was found for
both Sa1int and Sa6int although it was significant only
for the former (p < 0.001 and p = 0.21, respectively; see
Additional file 2: Figure S3).
We attempted to investigate the mechanisms driving
the observed temporal changes in the prevalence of
MGEs in the CC22 population. Antimicrobial use is
likely to constitute one of the main selective pressures
driving the epidemiology of resistance-associated MGEs.
Three elements showed a steady temporal decrease in
prevalence including P1-ermC, which mediates resist-
ance to erythromycin, a widely used drug in clinical
Fig. 3 Number of MGE gain and loss events across the MRSA CC22
phylogeny. Ancestral state reconstruction for carriage of P1-ermC, P2-hm,
SaPIsec, Sa1int and Sa6int was performed on MRSA CC22 phylogeny
using stochastic character mapping. The violin plots show the distribution
of estimated number of MGE gains and losses based on 1000 simulations
Fig. 4 Prevalence of analysed MGEs amongst MRSA CC22 isolates
between 2001 and 2010. MGEs that showed a significant temporal
change in frequency were P1-ermC, P2-hm, SaPIsec, Sa1int and
Sa6int. Prevalence shown as % of MRSA CC22 isolates in each year
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practice. Over the ten-year period between 2001 and
2010 there was a steady drop in the use of erythromycin
in the United Kingdom, a trend that has continued in re-
cent years [27, 28]. However, this has been accompanied
by an increase in the use of other macrolides, such
as clarithromycin and azithromycin (see Additional file
2: Figure S4), demonstrating changes in prescription
practices in accordance with clinical guidelines and im-
proved tolerability. The ermC gene has been previously
correlated with clarithromycin resistance in S. epidermi-
dis and the use of this macrolide was found to select
ermC-positive isolates [29]. It is therefore unclear
whether changes in macrolide usage could have resulted
in lower selective pressure on P1-ermC carriage leading
to its temporal shedding. Nevertheless, the loss of P1-
ermC over time correlated with a temporal reduction in
the number of erythromycin resistant CC22 isolates (see
Additional file 2: Figure S5). Out of the 678 CC22
isolates that were resistant to erythromycin, the majority
carried the P1-ermC plasmid (653/678), confirming that
this element represents the primary determinant of
macrolide resistance in the analysed CC22 population.
Although the mechanisms that have been driving the
temporal loss of P1-ermC will require further scrutiny,
more significantly this evolutionary change resulted in a
lower prevalence of related phenotypic resistance.
Finally, we investigated whether the changes observed
here in MGE composition had impacted on the genetic
diversity of CC22 at the core genome. An analysis of
pairwise SNP distances revealed a steady increase in
CC22 heterogeneity between 2001 and 2010 (see
Additional file 2: Figure S6). A Bayesian skyline plot of
inferred historical changes in the effective population
size of CC22 demonstrated that it rapidly expanded at
the beginning of the 1990s, which coincides with the
first reported isolation of the EMRSA-15 clone (Fig. 5).
This growth continued and reached a plateau around
the mid-1990s, with a further minor expansion
between 2000 and 2005 followed by a plateau. This
suggests that despite the apparent temporal loss of re-
sistance- and virulence-associated MGEs, CC22 has
maintained a stable population size over the corre-
sponding time period.
Discussion
Horizontal gene transfer represents one of the key
mechanisms of S. aureus evolution, mediating acquisi-
tion of virulence and antimicrobial resistance-associated
MGEs, which in turn drives the emergence of successful
MRSA clones [3]. However, the MGE composition varies
considerably between distinct MRSA populations and
can also be heterogeneous amongst isolates of the same
lineage [30, 31]. Here, we report novel insights into the
evolution of the MGE content in MRSA population. Uti-
lising WGS data we defined the content and prevalence
of MGEs across the CC22 population, a globally dissemi-
nated and prevalent MRSA lineage. This revealed that
the distribution of several variably occurring elements
(P1-ermC, P2-hm, SaPIsec, Sa1int and Sa6int) was
marked by a pattern of frequent carriage transitions in-
volving multiple loss and gain events. We found a sig-
nificant temporal pattern in the prevalence of these
MGEs. This suggests the existence of selective pressures
driving the long-term evolution of MGE carriage result-
ing in a measurable reduction or increase in the fre-
quency of specific MGEs.
Elements that increased in prevalence were phage
types Sa1int and Sa6int. Both have been reported to be
infrequent in other S. aureus CCs [20, 32]. Little is
known about the possible selective advantage of Sa1int
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or Sa6int acquisition. Carriage of virulence determinants
has been reported previously for Sa1int, namely the
exfoliative toxin gene eta [20]. However, this gene was
not found in any of the analysed CC22 isolates. In con-
trast, MGEs that showed a steady temporal decline in
prevalence across the CC22 population between 2001
and 2010, namely plasmids P1-ermC and P2-hm as well
as pathogenicity island SaPIsec, were all vectors of either
antimicrobial resistance or virulence genes. Plasmid
P1-ermC encodes the erythromycin ribosomal methylase
ErmC, conferring resistance to erythromycin and add-
itionally to clindamycin if the ermC gene is constitutively
expressed due to mutations in its regulatory region [33].
The ermC gene is a common determinant of erythro-
mycin resistance in S. aureus and other staphylococci,
and is mainly found on small multi-copy plasmids such
as P1-ermC [34]. The successful dissemination of this
plasmid type is evident in its wider distribution among
other MRSA lineages analysed here. This may reflect the
high levels of macrolide use in the UK, the third most
common group of antibiotics prescribed in clinical prac-
tice [35]. Consistently, the absence of this element in
certain S. aureus populations, such as isolates from com-
panion animals, has been linked with lack of selective
pressure due to lower erythromycin usage [36]. In
contrast to P1-ermC, the second plasmid P2-hm was not
observed outside the CC22 lineage, suggesting that the
element may be CC22-specific. This plasmid carried a
cluster of heavy metal resistance genes consisting of
cadA, copB, mco and arsAB. Interestingly, an integrated
plasmid carrying the same cluster of heavy metal resist-
ance genes has been also found in EMRSA-16 [22], indi-
cating an association of these resistance genes with
distinct HA-MRSA lineages. Occurrence of heavy metal
resistance genes in bacterial pathogens has been linked
with metal contamination in the environment as well as
co-selection due to antibiotic co-resistance or cross-
resistance [37]. Carriage of genes expressing copper
detoxification mechanisms such as CopB ATPase trans-
porter and multi-copper oxidase (MCO) may be also
associated with adaptation towards enhanced survival of
bacterial pathogens within the host. It has been observed
that copper might play an important role in innate im-
munity by enhancing bactericidal activity of macro-
phages, and resistance to copper has been associated
with virulence in various bacterial pathogens such as
Mycobacterium tuberculosis, Streptococcus pneumoniae
and Neisseria gonorrhoeae [38–41]. The S. aureus
chromosome commonly contains a conserved copper re-
sistance operon composed of copA and copZ genes [42].
Carriage of plasmid-associated copB and mco genes
further enhances copper tolerance in S. aureus, resulting
in a hyper-copper-resistance phenotype that might aid
survival in copper-rich environments [43]. Similar to P2-
hm, SaPIsec was restricted to CC22 isolates. The entero-
toxin C (SEC), encoded by the sec gene, belongs to the
family of staphylococcal pyrogenic exotoxins that act as
superantigens, inducing a non-specific T cell activation
[44]. Staphylococcal enterotoxins such as SEC also rep-
resent gastrointestinal toxins and have mostly been de-
scribed as causative factors of staphylococcal food
poisoning [45]. Recently, SEC has also been shown to be
a critical virulence factor in a rabbit model of staphylo-
coccal infective endocarditis and sepsis, both through
super-antigenicity and direct interaction with endothelial
cells [46]. Another study demonstrated that vaccination
against SEC provides protection against S. aureus
induced necrotizing pneumonia in a rabbit model of the
disease, further suggesting that SEC plays an important
role in S. aureus invasive disease [47].
Together, the three MGEs (P1-ermC, P2-hm and SaPI-
sec) represent elements that are likely to provide an ini-
tial selective advantage by altering the pathogenicity and
survival of invasive S. aureus. It is striking to observe a
common temporal trend of diminishing prevalence for
all three elements in CC22. Also, a temporal reduction
in the prevalence of an antibiotic resistance element
such as P1-ermC represents a unique evolutionary
trajectory for a hospital-associated pathogen. Further-
more, the loss of each element occurred across the
CC22 phylogeny with multiple presence-to-absence
transitions. This indicates that the evolutionary trend to-
wards falling frequency of MGEs involved the broader
CC22 population rather than being driven by expansion
of MGE-negative isolates. It has been suggested previ-
ously that the success of MRSA CC22 might be partly
driven by its ability to rapidly gain and lose MGEs under
changing environmental conditions [31]. Furthermore,
the temporal reduction of the MGE content appears to
be specific to CC22. A broader analysis of MGEs
amongst non-CC22 lineages was not conducted due to
small sample sizes for other CCs, but we observed that
the vast majority of CC30 isolates carried the previously
mentioned EMRSA-16-associated heavy metal resistance
plasmid at an overall prevalence of 97%. Similarly, the
CC30-associated pathogenicity islands, SaPI-2 and SaPI-
4, were detected in at least 96% of CC30 isolates,
demonstrating stable carriage by the study collection.
It has been observed previously that the epidemiology
of major MRSA lineages resembles a wave of expansion
followed by population equilibrium and then decline
[48]. While MRSA CC22 remains the dominant lineage
of HA-MRSA in the UK, the epidemiology of MRSA in
the UK healthcare setting has been shifting. A fall in
prevalence of EMRSA-16 has been widely reported
together with a decline in MRSA isolation rates
[13, 19, 49, 50]. This has been linked with an im-
plementation of various infection control measures
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across the UK hospitals [51, 52]. However, others reported
that the change in MRSA epidemiology began prior to the
onset of these infection control initiatives and was clone-
specific [13, 50]. Changing biology of the MRSA popula-
tion might have played a more critical role in the declining
rates of hospital MRSA infections [50]. The changing
MGE composition of CC22 should therefore be consid-
ered in the context of the shifting MRSA epidemiology. It
is unclear whether the loss of distinct MGEs reflects a
positively-selected evolutionary adaptation or loss of non-
essential elements due to diminishing selective pressure.
The latter might constitute changes in antimicrobial pre-
scription practices. An association between a reduced
consumption of macrolides and an increase in frequency
of susceptible isolates in MRSA population in a hospital
setting has been observed [52]. Other factors may be at
play, such as the decline in prevalence of a competitive
clone, namely EMRSA-16, providing that the analysed
here MGEs have played an important role in out-compet-
ing other prevalent MRSA lineages. A lower selective
pressure to maintain specific virulence and antimicrobial
resistance associated MGEs might also relate to the wider
changes in MRSA epidemiology. Our data shows that
MRSA CC22 has maintained a stable effective population
size between 2001 and 2010 despite dropping prevalence
of hospital acquired MRSA infections suggesting that this
lineage is likely well adapted to survival outside of clinical
setting. There is some evidence that the EMRSA-15 clone
might be common in the MRSA population outside of
hospital environment in the UK, based on isolates from
community associated-MRSA infections [53, 54]. An
asymptomatic carriage of this clone amongst healthy
young individuals with no risk association was also re-
ported in Ireland [55]. The changing composition of MGE
might therefore reflect loss of elements that are less crit-
ical for successful carriage or transmission within a
community.
Conclusions
The CC22 MRSA lineage has a flexible MGE compos-
ition based on the heterogeneous distribution of several
MGEs across its phylogeny, which is associated with
high frequency of MGE loss and acquisition events. The
evolutionary pattern of MGE flux correlated with the
temporal prevalence of studied MGEs. The evolutionary
changes observed here further indicate that CC22 can
rapidly alter its MGE composition, which in turn may
contribute to the successful dissemination and persist-
ence of this clone. In addition, the observed drop in
prevalence of an antimicrobial resistance-associated
MGE over time reveals a novel evolutionary trajectory
for an important hospital-associated bacterial pathogen,
which in turn might demonstrate adaptation to survival
outside of hospital setting.
Methods
Bacterial isolates
The 1193 S. aureus bacteraemia isolates studied here de-
rived from two sources. A total of 1013 isolates were
from a collection described previously that spanned the
period from 2001 to 2010 [56]. In brief, these were pre-
dominantly MRSA (N = 990), collected by the British
Society for Antimicrobial Chemotherapy (BSAC) who
coordinate antimicrobial resistance surveillance across
the United Kingdom and Ireland [57]. Diagnostic micro-
biology laboratories submit a defined number of
consecutive but non-duplicate S. aureus isolated from
blood cultures each year. A total of 47 centres contrib-
uted S. aureus bacteraemia isolates between 2001 and
2010. A further 180 non-duplicated isolates (all but one
MRSA) associated with bloodstream infection were
collected from hospitals in the East of England over the
same time period (apart from during 2008 or 2009).
Whole-genome sequencing, assembly and annotation
Genomic DNA was isolated using the Qiagen QIAxtrac-
tor system. Tagged DNA libraries were created using a
method adapted from a standard Illumina Indexing
protocol, as described previously [16]. Whole-genome
sequencing was performed on the Illumina HiSeq 2000
platform with 100 bp paired-end reads. Annotated
assemblies were produced as previously described [58].
Briefly, de novo assembly of whole genome sequences
was performed using Velvet v1.2 [59] with Velvet Opti-
miser v2.2.5 [60]. Contigs were scaffolded with SSPACE
[61] and sequence gaps closed using GapFiller [62]. The
assembled contigs were annotated using Prokka v1.11
[63] and S. aureus specific database from RefSeq [64].
Genotyping and phylogenetics
Multi-locus sequence typing based on the previously de-
scribed S. aureus typing scheme [6] was performed on
assembled genomes using an in-house pipeline, MLST
check [65]. To query evolutionary relationships between
isolates, single nucleotide polymorphisms (SNPs) were
detected by mapping paired-end reads against the S.
aureus HO 5096 0412 reference genome [9], using
SMALT version 0.7.4 [66]. After excluding MGEs from
the generated alignment, an approximately-maximum-
likelihood phylogenetic tree was generated using
FastTree [67]. Clonal complex specific phylogenies were
further reconstructed for CC22 and CC30. The align-
ment based on HO 5096 0412 genome was used for
CC22, whereas isolates belonging to CC30 were re--
mapped against the MRSA252 reference genome [22].
For each CC a core genome alignment was created by
excluding MGE regions, variable sites associated with re-
combination (detected with Gubbins [68]) and sites with
more than 5% proportion of gaps (i.e. sites with an
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ambiguous character). Maximum likelihood (ML) phylo-
genetic trees were generated using RAxML version 7.8.6
[69] based on the generalised time reversible (GTR)
model with GAMMA method of correction for among
site rate variation and 100 bootstrap replications [8].
Phylogenetic trees were annotated using Evolview [70, 71].
CC22 population demographic history was estimated
based on a subset of 100 isolates using Bayesian Evolu-
tionary Analysis Sampling Trees (BEAST) software
package v1.8.2 [72]. The MCMC chain was run for 50
million generations, sampling every 1000 states using the
HKY four discrete gamma substitution model. The Bayesian
population size model was tested with strict and lognormal-
relaxed molecular clocks, each run in triplicate. Only the
strict clock model completed with good convergence of
chains and a suitable effective sample size parameter. The
Bayesian skyline plot was generated with Tracer v1.5.
MGE analysis
Genome fragments representing MGEs were defined as
described previously [8]. Briefly, the presence of variably
distributed sequence fragments of >1 kbp across assem-
blies of all CC22 isolates was determined, followed by
annotation and Basic Local Alignment Search Tool
(BLAST) analysis to determine the class of putative
MGE. Contigs were considered to represent a putative
plasmid if presence of a rep gene was detected or if the
element shared sequence similarity with a previously
identified plasmid, as defined by a BLAST search. Se-
quence fragments that were >1 kbp but contained a sin-
gle CDS only were excluded from further analyses as the
type of MGE could not be defined. A mobile genetic
element database was collated from the defined se-
quence fragments and applied to screen the distribution
of each sequence across all isolates using the short-read
sequence typing tool (SRST2) [73]. If the presence of an
element was detected based on short read mapping, this
was further verified by assembly alignment with the use
of MUMmer [74]. MGEs were recorded as present
whether found assembled on a single contig or occurring
as fragmented assemblies.
Statistical analysis
Analysis of trait evolution pattern for the distribution of
MGEs was conducted on the ML phylogeny of CC22.
Root-to-tip distances were calculated using the TempEst
tool [75]. The phylogenetic signal of MGE distribution
as well as the logistic regression of MGE distribution as
a categorical binary value (presence/absence) and
predictor variables (year of sampling, root-to-tip diver-
gence) was measured using binaryPGLMM function
from R package ape. The ancestral state reconstruction
(ASR) was performed with stochastic character mapping
using the make.simmap function of the R package
phytools. Two evolutionary models were compared:
equal rates (ER) and all-rates-different (ARD) by
estimating the Akaike information criterion (AIC) using
the fitDiscrete function of R package geiger. The ARD
model gave a better fit and was applied in ASR. The re-
constructions were run with 1000 simulations.
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